The GST Council's next-generation reform package, effective September 22, 2025, introduced sweeping rate rationalisations. The revised structure shifts to a simplified two-slab system (5% and 18%), reducing tax burdens on essentials. Key pharmaceutical benefits include 33 life-saving drugs and diagnostic kits moved from 12% to 0%, Ayurveda/Unani/Homoeopathy medicines reduced from 12% to 5%, and job work in pharma manufacturing cut from 12% to 5%. Household costs are projected to fall by up to 13%, with the reform expected to add 0.1 percentage point to GDP growth.
GST 2.0 Reforms: Rate Rationalisation Brings Relief to Common Man and Pharma Sector
GST 2.0 reforms rationalise tax slabs to 5% and 18%, offering relief on life-saving drugs, medicines, and essentials, effective September 22, 2025.
Key facts
- GST 2.0 rationalises tax slabs to 5% and 18% effective September 22, 2025.
- Life-saving drugs and medicines receive significant tax relief.
- Essential commodities benefit from reduced GST rates.
- Pharma sector gains from simplified compliance and lower duty.
- Reform benefits the common man through reduced prices on daily needs.
- Rate rationalisation improves India's ease of doing business.
6-axis classification
Appears in these topics
Practice MCQ from this story
SolveTap an option below. Correct or incorrect feedback appears instantly.
Under GST 2.0 reforms effective September 22, 2025, how many life-saving drugs were moved to the 0% GST category?
Under GST 2.0 reforms, 33 life-saving drugs and diagnostic kits were moved from 12% to 0% GST.
Source: PIB / EY India
Frequently asked questions
What are the key changes introduced under GST 2.0 rate rationalisation?
GST 2.0 rationalises tax slabs to two primary rates — 5% and 18% — effective September 22, 2025. Life-saving drugs, medicines, and essential commodities receive significant tax relief under this reform.
When did GST 2.0 reforms come into effect?
GST 2.0 reforms came into effect on September 22, 2025, simplifying the tax slab structure and reducing rates on essential goods and pharmaceuticals.
How does GST 2.0 benefit the pharma sector?
The pharma sector benefits from lower duty on life-saving drugs and simplified compliance under GST 2.0, making medicines more affordable and reducing the regulatory burden on pharmaceutical companies.
How does GST rate rationalisation improve ease of doing business in India?
By consolidating multiple tax slabs into a simplified 5% and 18% structure, GST 2.0 reduces compliance complexity for businesses, lowers costs on essential inputs, and makes India's indirect tax regime more predictable and transparent.
What impact does GST 2.0 have on the common man?
GST 2.0 benefits the common man by reducing taxes on daily essentials and life-saving medicines, directly lowering prices on goods and improving affordability for households.
Was this useful?
Share corrections or missing exam angles with the editorial team.
Send feedback